Search Results

Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.

Guardant Health, Inc. (Nasdaq: GH) announced its research collaborators from Washington University’s Siteman Cancer Center will lead an oral presentation today at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting highlighting the potential role of liquid biopsy in addressing racial inequities in enrollment in clinical trials and in the use of targeted therapies for advanced breast cancer.

Looking for a biopharma job in or near Washington, D.C.? Check out these five top companies hiring life sciences professionals like you.

Calidi Biotherapeutics, Inc. today announced the appointment of Dr. George E. Peoples, MD, FACS, to the company’s Board of Directors, effective July 1, 2024.

Vaxart, Inc. announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024.

George Medicines announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately.

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies announced that translational immunology expert George Vratsanos, M.D., FACR, is joining its board of directors.